Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 1 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
14 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
BIOKEY from Diepenbeek, company number BE0719913808, closed financial year 2025 with a result of € -26,728 after tax. For that financial year BIOKEY recorded a gross margin of € -25,987 and equity of € -203,275. Compared with financial year 2024, the result moved from € -48,865 to € -26,728. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 17, 2025.
€ -203,275
▼ € 26,728 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -26,728
▲ 45 % less loss than in 2024
Profit after tax over the fiscal year.
€ 616
▲ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -226,525.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -4,669 | € -50,810 | € -48,288 | € -25,987 | ▲ € 22,301 |
| Profit after taxes | € -5,418 | € -54,899 | € -48,865 | € -26,728 | ▲ € 22,137 |
| Equity | € -72,783 | € -127,682 | € -176,547 | € -203,275 | ▼ € 26,728 |
| Total debts | € 79,749 | € 148,551 | € 182,129 | € 205,205 | ▲ 13% |
| Cash | € 109 | € 17,622 | € 581 | € 616 | ▲ 6% |
| Retained profit | € -96,033 | € -150,932 | € -199,797 | € -226,525 | ▼ € 26,728 |
| Balance sheet total | € 6,966 | € 20,869 | € 5,582 | € 1,931 | ▼ 65% |
Key figures of BIOKEY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 November 2026.
What happened to BIOKEY?
What happened at BIOKEY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 26,728. Source: NBB ↗
- Ilse Roodlink stepped down as director. NBB
- New establishment in Diepenbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 5,418 loss in 2022 to € 26,728 loss in 2025.
A new publication or filing at BIOKEY? We notify you, reason included.
Follow BIOKEYDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of IDEA FAMILY comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
BIOKEYBehind BIOKEY are Ingrid Brands, Jennifer Bath and Dirk Van Hyfte. The shares are held by IDEA FAMILY (80%).
Directors
According to the 2025 annual accounts
· until 2025
Shareholders
80%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Agoralaan Abis
3590 Diepenbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
All companies at this address →Clinitude
€ 419,430 gross margin · 2025
FOx Biosystems
€ -763,895 gross margin · 2023
Highstar Engineering
€ -41,079 gross margin · 2024
IDEA FAMILY same network
€ -3,258 gross margin · 2025
BIOSTRAND same network
€ -2.1 million gross margin · 2025
+9 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0719.913.808
- VAT number
- BE 0719.913.808
- Registered office
- Agoralaan Abis, 3590 Diepenbeek
- Names & denominations
- BIOKEY
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 February 2019
- Peppol
- Active · Active since 5 Dec 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige diensten op het gebied van informatietechnologie en computer
Overige zakelijke dienstverlening, neg
Ontwerpen van computerprogramma’s
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Computerconsultancy-activiteiten